|Native name||Vaccinazione anti-COVID 19|
|Date||27 December 2020 – present|
|Location||2914 main vaccination centers|
|Organised by||Ministry of Health (Italy)|
|Participants||91,096,965 doses administered and 43,541,974 fully vaccinated people as of 09 Nov 2021|
|Outcome||72.13% of the Italian population is fully vaccinated|
|Website||Health Ministry – COVID-19 vaccination plan|
The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.
The vaccination campaign was managed by the Ministry of Health and the special commissioner Domenico Arcuri until 1 March 2021,when he was replaced by Army General Francesco Paolo Figliuolo.
Vaccination against COVID-19 is mandatory for all workers in Italy since October 15.
In the first months of the vaccination campaign, the governmental agencies targeted the health medical and administrative personnel, together with the guests and personnel of nursing homes.
In the second phase of the campaign, elderly people and public service personnel should receive the vaccine.
The Pfizer–BioNTech COVID-19 vaccine was authorized by the European Commission on 21 December 2020, on the same day after receiving recommendation for granting conditional marketing authorization by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).
The Italian government bought, in a coordinated effort with the EU Commission, various types of COVID-19 vaccine, including the Pfizer–BioNTech COVID-19 vaccine, and the ones produced by Moderna, University of Oxford–AstraZeneca, Sanofi, and Johnson & Johnson.
|Pfizer–BioNTech COVID-19 vaccine||21 December 2020||27 December 2020|
|Moderna||6 January 2021||12 January 2021|
|Oxford-AstraZeneca||29 January 2021||6 February 2021|
|Janssen||11 March 2021||21 April 2021|
|Vaccine||Type (technology)||Phase I||Phase II||Phase III|
|GRAd-COV2||Viral vector||Completed||Completed||In progress|
|COVID-eVax||DNA||In progress||In progress||Not yet|
The vaccination campaign started on 27 December 2020, when Italy received 9,750 doses of the Pfizer–BioNTech COVID-19 vaccine. These doses were entirely used in the following days to vaccinate part of the medical and health personnel of hospitals.
The Italian vaccination campaign was coordinated and agreed with the European Union (EU). The EU countries, as per previous agreements, received the vaccine provisions according to a centralized plan developed by the European Commission.
On 30 December 2020, 359,775 doses of vaccine were delivered by Pfizer–BioNTech.
On 31 December 2020, 110,175 doses of vaccine were delivered by Pfizer–BioNTech.
From 30 December 2020 to 1 January 2021, 469,950 doses of vaccine were delivered by Pfizer-BioNTech.
From 5 January 2021 to 7 January 2021, Pfizer-BioNTech delivered another 438 750 doses. This type of vaccine must be stored at -70 °C. The first Italian region to start with vaccinations was Lazio, at the Spallanzani Hospital in Rome. Subsequently, the vaccines were distributed in the other Italian regions.
On 6 January 2021, the European Medicines Agency (EMA) gave its authorization for the Moderna vaccine.
According to a scientific study of COVID-19 virology, the Pfizer–BioNTech COVID-19 vaccine also protects against the two mutations of the virus that have spread in the United Kingdom and South Africa.
Both strains share a common mutation called N501Y, a slight alteration at one point in the protein that covers the virus.
On 10 January 2021, the Campania region in Italy had the highest percentage of administration compared to the doses possessed. It also claimed to have exhausted the stock.
On 11 January 2021, 75,075 doses of vaccine were delivered by Pfizer–BioNTech.
On 12 January 2021, 47,000 doses of vaccine were delivered by Moderna.
On 11 and 12 January 2021, 488,475 doses were delivered.
Pfizer has reduced vaccine availability by 29% as of 18 January 2021.On 16 January 2021, 800 doses of Moderna vaccine were lost due to freezer failure in Forlì.
On 18 and 19 January 2021, there are further delays and reductions in the number of Pfizer–BioNTech COVID-19 vaccines.
On 20 January 2021, the vaccination campaign was slowed down due to a lack of vaccine stock.
On 20 January 2021, AstraZeneca delays the delivery of the vaccine and reduces the expected quantities for deliveries across Europe.
The delay in vaccine supply is delaying the vaccination campaign. On January 29, 2021, Moderna also cut vaccine supplies by 20%. About 300,000 doses are missing in the supply of vaccines provided for in the agreements with Moderna.
The European Union is in sharp confrontation with AstraZeneca on the timing and quantity of vaccine supplies. This leads to a serious delay in the Italian and European vaccination campaign.
On 30 January 2021, AIFA limits the administration of the AstraZeneca vaccine from 18 to 55 years.
On 2 February 2021, the vaccination campaign is slowing sharply due to a lack of deliveries of vaccines by pharmaceutical companies.
On 6 February 2021, the first 249,600 doses of the AstraZeneca vaccine arrived in Italy.
On 12 February 2021, the Genoese architect Renzo Piano was the first to undergo vaccination on Silver Vaccine Day that opens the vaccination campaign for the persons over 80 years old in Liguria.
On 17 February 2021, AIFA extend the administration of the AstraZeneca vaccine until 65 years old.
On 18 February 2021, the senator for life, Liliana Segre was vaccinated at Fatebenefratelli Hospital in Milan. She was received by the President of the Lombardy Region, Attilio Fontana, and the Vice President and Assessor of Welfare, Letizia Moratti.
On 20 February 2021, AstraZeneca reduced vaccine supplies by 15%.
On 23 February 2021, AstraZeneca plans to supply less than half of the doses of vaccine preordered to the European Union.
On 26 February 2021, the vaccination clinics increased to 1436, up from the initial 293.
On 1 March 2021, The General of the Italian Army Francesco Paolo Figliuolo is the new special commissioner to replace Domenico Arcuri.
On 9 March 2021, The President of the Italian Republic, Sergio Mattarella was vaccinated in the Spallanzani Hospital. The president was given a dose of Moderna vaccine.
On 11 March 2021, AIFA banned the use in Italy of a batch (number ABV2856) of the AstraZeneca vaccine for checks in relation to the deaths of two men in Sicily after administration of the vaccine.
On 15 March 2021, AIFA suspends the AstraZeneca vaccine throughout Italy on a temporary basis for investigations into death cases after vaccination.
On 19 March 2021, AIFA revoked the ban for AstraZeneca, vaccinations have resumed.
On 20 March 2021, the special commissioner, Army General Francesco Paolo Figliuolo and the chief of Protezione Civile Fabrizio Curcio were vaccinated with the AstraZeneca vaccine.
On 25 March 2021, the name of the AstraZeneca vaccine was changed to Vaxzevria in the European Union.
On 30 March 2021, Prime Minister Mario Draghi and his wife Maria Serenella Cappello were vaccinated with the AstraZeneca vaccine in the Termini station hub in Rome, as required by the Lazio Region vaccination plan.
On 3 April 2021, a firebombing occurred at a vaccine cold storage site in Brescia but did not damage the building's electrical supply, meaning vaccines remained usable.
On 6 April 2021, AstraZeneca postponed delivery of 50% doses scheduled for 14 April 2021.
Meanwhile, Oxford University's Jenner Institute is suspending testing of the vaccine on children. The Oxford University's Jenner Institute decision was made pending an analysis of the possible links between the drug and episodes of thrombosis among adults.
In Italy, 54% of doses of AstraZeneca vaccine have been administered to date (2,218,038 out of 4,098,800 delivered), according to the Ministero della Salute, while for Moderna vaccine the percentage drops to 50% (658,403 out of 1,328,200). Pfizer vaccine has a 96% administration rate, (8,375,625 out of 8,709,480). In total, out of 14,136,480 doses of the three vaccines arrived in Italy, 11,252,066 were administered, about 80%.
On 13 April 2021, 184,000 doses of the Janssen vaccine arrived in Italy, however Johnson & Johnson announced that it would delay deliveries of its vaccines to Europe.
AIFA has cautiously suspended distribution to vaccination centers pending information from the United States where the Janssen vaccine has been suspended for investigation into suspicious deaths and thrombosis disorders following the administration of the Janssen vaccine.
On 22 April 2021, Johnson & Johnson vaccine started to administration in Italy.
On 1 May 2021, Italy reached 20 million administered vaccine doses. At this point, the country had vaccinated 14 million with at least a single dose and 6 million are fully vaccinated.
On 2 May 2021, two anti-vaxxers were arrested and charged with terrorism offences for the firebombing at the Brescia vaccination centre.
On 10 May 2021, a nurse accidentally injected a patient with 6 doses of Pfizer BioNTech.
On 22 May 2021, Italy reached 30 million administered vaccine doses.At this point, the country has 9.9 million people vaccinated with a double dose.
On 1 June 2021, Italy reached 35 million administered vaccine doses. At this point, the country has 12 million people vaccinated with a double dose.
On 10 June 2021, Italy reached 40 million administered vaccine doses.
On 28 June 2021, Italy reached 50 million administered vaccine doses.
On 16 July 2021, Italy reached 60 million administered vaccine doses.At this point, the country has 25 million people vaccinated with a double dose.
On 5 August 2021, Italy reached 70 million administered vaccine doses.
On 9 September 2021, Italy reached 80 million administered vaccine doses.
Third dose vaccinations begin to fragile subjects and health workers.
On 3 November 2021, Italy reached 90 million administered vaccine doses.
On 4 November 2021, The President of the Italian Republic, Sergio Mattarella, received the third dose of the vaccine in the Spallanzani Hospital.
|Vaccinations in Italy|
|Vaccinations in Italian regions|
• The quantities delivered are currently calculated at five doses per vial. Therefore, any percentage values above 100 show the use of the sixth dose.
|Vaccinations by age groups|
The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government. As part of the Department of Health, the TGA regulates the quality, supply and advertising of medicines, pathology devices, medical devices, blood products and most other therapeutics. Any items that claim to have a therapeutic effect, are involved in the administration of medication, or are otherwise covered by the Therapeutic Goods Act 1989, the Therapeutic Goods Regulations 1990, or a ministerial order, must be approved by the TGA and registered in the Australian Register of Therapeutic Goods.
COVID-19 vaccination in Switzerland is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine is not included in the Australian vaccination program.
COVID-19 vaccination in Romania started on 27 December 2020. It was announced that the process would be divided into three phases. Medical personnel would be vaccinated first, followed by the population at risk, and finally by the rest of the population. Vaccination was declared free and non-mandatory. As of May 2021, four types of vaccines were authorized to be used in Romania. This is the largest vaccination campaign in the modern history of Romania.
The COVID-19 vaccination programme in the Republic of Ireland is an ongoing mass immunisation campaign that began on 29 December 2020 in response to the COVID-19 pandemic in the Republic of Ireland. Ireland's vaccination rollout has been praised as one of the most successful rollouts in the world and is currently ranked number one in the European Union in terms of its percentage of adult population fully vaccinated.
The COVID-19 vaccination program in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic in Canada. Some provinces have asked local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history; it started in mid-December 2020 and is currently ongoing.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
Cape Verde has begun vaccinations against COVID-19.
The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The COVID-19 virus was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. Sinopharm COVID-19 vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021.
The COVID-19 vaccination campaign in Quebec is an ongoing provincial effort to distribute and administer the vaccine against COVID-19.
COVID-19 vaccination in South Korea is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks fifth in the world and second in Asia.
The COVID-19 vaccination program in Argentina is an ongoing effort of mass immunization. Vaccination against COVID-19 began in Argentina on 29 December 2020 aiming at health professionals. Argentina struck a deal with the United Kingdom in November 2020 for a British made vaccine produced by the pharmaceutical company AstraZeneca and the University of Oxford. The vaccines are part of a deal where Argentina received 22.4 million doses. During the first week, 39,599 doses were applied to health professionals.
Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.
The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on January 17, 2021, when the country had 210 thousand deaths.
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, Sinopharm's BBIBP-CorV accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna COVID-19 vaccine through COVAX.
COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021.